Single Cell Technologies and their Fields of Application (Tumor Cells)

With its 12th edition, Trends in Single Cell Analysis continues the Life Science Innovation series, providing insights into pioneering single-cell technologies and their applications in cancer research and liquid biopsy.

This edition will feature advances in multiplexed imaging of circulating tumor cells for precision oncology, single-cell mechanical characterization with high-throughput CTC classification, and multiomic analysis of CTCs and ctDNA using Parsortix. We look forward to welcoming leading experts from academia and industry who will share cutting-edge technologies and concepts shaping the future of single-cell analysis.

Programme

• Welcoming speech:
  Dr. Thomas Heck, Life Science Center Duesseldorf

Academia

• Moderation: Prof. Dr. Hans Neubauer, PhD, University Hospital Duesseldorf
  50 marker multiplexed imaging unlocks potential of circulating tumour cells to guide precision oncologyA/Prof. Therese Becker, PhD
  CCDR Leader, Ingham Institute for Applied Medical Research, Australia
  Dr. John Lock Scientia Research Group Leader, University of New South Wales, Australia
  A/Prof. Therese Becker & Dr. John Lock will present how advanced multiplexed imaging with 50+ markers revolutionizes circulating tumor cell (CTC) analysis, enabling precise insights into resistance phenotypes and precision oncology.
• Moderation: Prof. Dr. Nikolas Stoecklein, MD, University Hospital Duesseldorf
  Single-cell mechanical characterization and high-throughput CTC classificationProf. Chann Lagadec, PhD
  ONCOLille Cancer Institute; CANTHER “Cancer Heterogeneity, Plasticity and Resistance to Therapies”, Université de Lille, France
  Prof. Chann Lagadec will showcase novel biomechanical single-cell characterization approaches that reveal how cancer cell mechanics drive plasticity and metastatic potential.

Companies & Technologies

• Moderation: Dr. André Franken, University Hospital Duesseldorf
  Multiomic analysis of CTCs and ctDNA from blood samples using parsortix
  Dr. Anne-Sophie Pailhes-Jimenez
  Senior Director, R&D, ANGLE Europe Limited, UK
  Dr. Anne-Sophie Pailhes-Jimenez will introduce a dual-analyte liquid biopsy strategy using Parsortix, combining CTC and ctDNA profiling to capture tumor evolution and therapeutic response.
  Moderation: Prof. Dr. Nikolas Stoecklein, MD, University Hospital Duesseldorf

Organizer: LifeScienceNet Duesseldorf and the Liquid Biopsy Center Duesseldorf (LBCD) of the University Hospital Duesseldorf